Radiopharm Theranostics Limited · OTC:RDPTF

Radiopharm Theranostics Limited financial statements

Radiopharm Theranostics Limited's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in AUD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021
Revenue2.77M3.63M299.2K292.4K8.83K0
Cost of revenue4.92M3.59M2.98M
Gross profit-2.15M39.3K299.2K292.4K-2.97M
Research and development50.0M27.5M23.1M22.6M7.49M
Selling, general and administrative18.6M12.4M300.6K
Operating income-68.3M-38.2M-47.2M-34.5M-19.9M-484.8K
Depreciation and amortization7.33K2.60M3.13M3.30M2.98M1.16M
EBITDA-68.3M-35.6M-44.1M-31.2M-16.9M678.7K
Interest expense112.4K65.3K642.9K86.1K9.35M0
Income before tax-56.9M-38.2M-47.9M-34.6M-30.3M-485.2K
Income tax-54.4K103.3K96.4K38.0K44.4K-1.16M
Net income-55.1M-38.3M-47.9M-34.6M-30.3M-485.2K
Earnings per share, basic-0.02-1.76-12.41-11.32-0.11-0.00
Earnings per share, diluted-1.76-12.41-11.32

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021
Cash and equivalents4.14M29.1M18.6M11.7M27.0M27.1K
Receivables17.4M10.4M987.4K4.47M56.5K6.35K
Inventory1-6.35K
Current assets21.9M39.9M22.8M27.3M33.4K
Property, plant and equipment53.5K60.8K1.58K
Total assets60.1M86.5M72.0M83.4M33.4K
Accounts payable5.47M9.34M10.9M5.12M1.19M64.4K
Current liabilities18.9M14.9M17.6M7.88M158.1K
Total debt59.0K
Total liabilities37.8M43.6M44.7M20.4M158.1K
Shareholders' equity24.7M42.9M27.4M45.6M63.0M-124.7K
Shares outstanding3.54B279.8M277.5M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021
Cash from operations-52.8M-36.6M-23.0M-23.2M-9.91M-32.9K
Capital spending-52.8M-45.3K-28.3M-1
Free cash flow-52.8M-23.2M-38.2M-32.9K
Cash from investing-5.42M1.77M-320.0K-1.53M-28.4M-28.4M
Cash from financing33.4M45.4M30.2M9.22M65.1M60.0K
Share buybacks-4.83M1.00K
Change in cash-25.0M10.6M6.90M-15.5M27.0M27.1K